1. Home
  2. NODK vs AVR Comparison

NODK vs AVR Comparison

Compare NODK & AVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NODK
  • AVR
  • Stock Information
  • Founded
  • NODK 1946
  • AVR 1999
  • Country
  • NODK United States
  • AVR Australia
  • Employees
  • NODK N/A
  • AVR N/A
  • Industry
  • NODK Property-Casualty Insurers
  • AVR
  • Sector
  • NODK Finance
  • AVR
  • Exchange
  • NODK Nasdaq
  • AVR NYSE
  • Market Cap
  • NODK 261.8M
  • AVR 241.5M
  • IPO Year
  • NODK 2017
  • AVR 2024
  • Fundamental
  • Price
  • NODK $12.25
  • AVR $4.47
  • Analyst Decision
  • NODK
  • AVR Strong Buy
  • Analyst Count
  • NODK 0
  • AVR 4
  • Target Price
  • NODK N/A
  • AVR $16.50
  • AVG Volume (30 Days)
  • NODK 14.6K
  • AVR 257.0K
  • Earning Date
  • NODK 05-16-2025
  • AVR 05-20-2025
  • Dividend Yield
  • NODK N/A
  • AVR N/A
  • EPS Growth
  • NODK N/A
  • AVR N/A
  • EPS
  • NODK N/A
  • AVR N/A
  • Revenue
  • NODK $325,204,000.00
  • AVR $2,703,000.00
  • Revenue This Year
  • NODK N/A
  • AVR $29.52
  • Revenue Next Year
  • NODK N/A
  • AVR $204.83
  • P/E Ratio
  • NODK $39.97
  • AVR N/A
  • Revenue Growth
  • NODK 6.97
  • AVR N/A
  • 52 Week Low
  • NODK $12.02
  • AVR $2.34
  • 52 Week High
  • NODK $17.24
  • AVR $8.79
  • Technical
  • Relative Strength Index (RSI)
  • NODK 51.89
  • AVR N/A
  • Support Level
  • NODK $12.02
  • AVR N/A
  • Resistance Level
  • NODK $13.07
  • AVR N/A
  • Average True Range (ATR)
  • NODK 0.41
  • AVR 0.00
  • MACD
  • NODK 0.04
  • AVR 0.00
  • Stochastic Oscillator
  • NODK 75.08
  • AVR 0.00

About NODK NI Holdings Inc.

NI Holdings Inc is a stockholding company. The company's operating segments include private passenger auto insurance, non-standard auto insurance, home and farm insurance, crop insurance, commercial insurance, and others. The company operates only in USA.

About AVR ANTERIS TECHNOLOGIES GLOBAL CORP

Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.

Share on Social Networks: